{"Antibody-drug": [0], "conjugate": [1], "(ADC)": [2], "is": [3], "typically": [4], "composed": [5], "of": [6, 26, 42, 49, 57], "a": [7, 14, 18], "monoclonal": [8], "antibody": [9], "(mAbs)": [10], "covalently": [11], "attached": [12], "to": [13, 36], "cytotoxic": [15], "drug": [16], "via": [17], "chemical": [19], "linker.": [20], "It": [21], "combines": [22], "both": [23], "the": [24, 50, 53, 61], "advantages": [25], "highly": [27, 32], "specific": [28], "targeting": [29], "ability": [30], "and": [31, 39, 55], "potent": [33], "killing": [34], "effect": [35], "achieve": [37], "accurate": [38], "efficient": [40], "elimination": [41], "cancer": [43], "cells,": [44], "which": [45], "has": [46], "become": [47], "one": [48], "hotspots": [51], "for": [52], "research": [54], "development": [56], "anticancer": [58], "drugs.": [59], "Since": [60], "first": [62], "ADC,": [63], "Mylotarg": [64]}